Comprehensive medication guide to {drug} including estimated pricing, availability information, side effects, and how to find it in stock at your local pharmacy.
Effient (Prasugrel) is a prescription antiplatelet medication used to reduce the risk of blood clots in patients with acute coronary syndromes (ACS) who have undergone percutaneous coronary intervention (PCI), such as stent placement. It is always taken in combination with aspirin. Effient belongs to the thienopyridine class of P2Y12 platelet inhibitors and is manufactured by Daiichi Sankyo and Eli Lilly. It was FDA-approved to help prevent heart attacks, strokes, and stent thrombosis in patients who have had a coronary stent placed.
Effient is a prodrug that gets converted into its active form in the body. The active metabolite irreversibly binds to and blocks the P2Y12 ADP receptor on the surface of platelets. By blocking this receptor, Effient prevents ADP-mediated platelet activation and aggregation, which reduces the formation of dangerous blood clots. This mechanism is especially important in patients with coronary stents, where clot formation can lead to life-threatening stent thrombosis. The effects last for the lifespan of the platelet (7–10 days).
The standard maintenance dose is 10 mg once daily. Patients weighing less than 60 kg are typically prescribed the 5 mg dose.
Effient (Prasugrel) scores a 75 out of 100 on our findability scale, meaning it is generally available at most pharmacies. Generic Prasugrel is widely stocked, though brand-name Effient may not be carried at every location. Because Prasugrel is a niche cardiac medication prescribed primarily after percutaneous coronary intervention (PCI), smaller or independent pharmacies may not keep it on hand. If your pharmacy is out of stock, most can order it within 1–2 business days. There are no major FDA-listed shortages for Prasugrel as of early 2026.
Struggling to find {drug} in stock? We'll call the pharmacies, sit on hold, and find you one that can fill your prescription.
Effient is most commonly prescribed by cardiologists and interventional cardiologists, typically initiated during or after a PCI procedure. Internal medicine physicians, emergency medicine doctors, and hospitalists may also prescribe or continue Effient therapy. Because Effient is used specifically for acute coronary syndrome patients managed with PCI, it is not typically prescribed in a primary care or telehealth setting without cardiology involvement.
No, Effient (Prasugrel) is not a controlled substance. It does not have a DEA schedule and has no potential for abuse or dependence. It is a standard prescription medication that can be prescribed and refilled without the restrictions that apply to controlled substances.
Serious side effects include significant or fatal bleeding, thrombotic thrombocytopenic purpura (TTP), intracranial hemorrhage, gastrointestinal bleeding, and hypersensitivity reactions including anaphylaxis. Effient carries a boxed warning about bleeding risk. Contact your doctor immediately if you experience unusual or prolonged bleeding.
Effient (Prasugrel) is an effective and widely available antiplatelet medication for patients with acute coronary syndromes who have undergone PCI. With generic Prasugrel now available, the cost has dropped significantly — from hundreds of dollars per month for brand Effient to as low as $19 with a discount card. Most pharmacies stock the generic version, and insurance coverage is generally favorable. If you are having difficulty finding Effient or Prasugrel in stock, Medfinder can help you locate a pharmacy near you that has it available. Always consult your cardiologist before making any changes to your antiplatelet therapy.
%2C%20Color%3DOriginal.png)
